Fresenius Medical Care 

M$1,591.02
271
-M$0-0% Tuesday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
May 25
M$21.47
May 24
M$21.47
May 23
M$21.36
May 22
M$28.25
May 21
M$32.55
10Y Growth
4.84%
5Y Growth
2.01%
3Y Growth
-8.74%
1Y Growth
N/A

Earnings

25FebExpected
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
5.4
9.89
14.39
18.88
Expected EPS
18.882455079398653
Actual EPS
N/A

Financials

2.56%Profit Margin
Profitable
2018
2019
2020
2021
2022
2023
366.72BRevenue
9.39BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FME.MX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, ambulant treatment, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Show more...
CEO
ISIN
DE0005785802

Listings

0 Comments

Share your thoughts

FAQ

What is Fresenius Medical Care stock price today?
The current price of FME.MX is M$1,591.02 MXN — it has decreased by -0% in the past 24 hours. Watch Fresenius Medical Care stock price performance more closely on the chart.
What is Fresenius Medical Care stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Fresenius Medical Care stocks are traded under the ticker FME.MX.
What is Fresenius Medical Care revenue for the last year?
Fresenius Medical Care revenue for the last year amounts to 366.72B MXN.
What is Fresenius Medical Care net income for the last year?
FME.MX net income for the last year is 9.39B MXN.
Does Fresenius Medical Care pay dividends?
Yes, FME.MX dividends are paid annual. The last dividend per share was 21.47 MXN. As of today, Dividend Yield (FWD)% is 0%.
When did Fresenius Medical Care complete a stock split?
The last stock split for Fresenius Medical Care was on December 04, 2012 with a ratio of 2:1.